The appeal lodged by the opponent (appellant) lies from the opposition division's decision to reject the opposition against European patent No. 2 691 417. The patent is entitled "Antibody Fc…
The applicant lodged an appeal against the decision of the examining division refusing European patent application No. 12002842.8.
On 5 October 2022 oral proceedings took place, during which the…
Opposition division maintained European patent No. 2 785 807 ("the patent") in its form modified on the basis of the auxiliary request 1. Opponent 2 ("appellant") appealed this decision.
The…
The appeal of the applicant (appellant) lies from a decision of an examining division, refusing the European patent application No. 09 757 250.7 with the title "Pestivirus replicons providing an…
Korean patent office follows JPTO, USPTO, CIPO and INPI (Brazil) with which INPI already has a PPH agreement
This decision concerns the appeal filed by the opponent (appellant) against the opposition division's interlocutory decision which held the European patent in an amended form.
Claim 1 of the main…
European patent No. 2 522 717 is based on European patent application No. 12 160 789.9, entitled "Oligopeptide-free cell culture media", filed as a divisional application of the earlier European…
Montenegro loses its status of extension state and becomes, as of 01/10/2022, a new full member of the EPC, bringing the number of EPC member states to 39.
European patent 2 451 486 ("the patent") was granted with independent claim 1 relating to:
"A conjugate for use in medicine, the conjugate comprising an L-asparaginase from Erwinia chrysanthemi…
Appeals have been filed by the opponent and the patent proprietor against the opposition division’s interlocutory decision to maintain European patent No. 2 170 949 in amended form according to…
